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OBJECTIVES: Hepatitis B virus (HBV) is a major blood-borne and sexually transmitted infectious agent that 
is a significant global public health issue. The aim of this study was to determine the seroprevalence and risk 
factors of HBV among pregnant women attending the antenatal clinic of the Hawassa University referral hos-
pital in Ethiopia.
METHODS: A cross-sectional study was conducted from April to May, 2015. A total of 269 consecutive preg-
nant women attending antenatal consultations were enrolled. Sociodemographic information and data regard-
ing possible risk factors were collected using a structured questionnaire. Hepatitis B surface antigen (HBsAg) 
screening was performed using an enzyme-linked immunosorbent assay, and the data were analyzed.
RESULTS: The overall seroprevalence of HBsAg among the 269 participants enrolled in the study was 7.8% 
(n=21). The prevalence of human immunodeficiency virus (HIV) infection was 5.2% (n=14), of whom two 
participants (14.2%) were also positive for HBsAg. Study participants with no formal education (odds ratio 
[OR], 3.68; 95% confidence interval [CI], 1.27 to 10.68; p<0.05) were more likely to be infected with HBV 
than those who had completed at least secondary school. Although HBsAg was detected more often in preg-
nant women who had multiple exposure factors (8.8%, n=13) than in pregnant women who had not experi-
enced possible risk factors (4%, n=1), this difference was not statistically significant (OR, 2.33; 95%CI, 0.29 
to 18.63).
CONCLUSIONS: A high prevalence of HBV infection was detected in the study population. Neither the type 
of risk factors nor exposure to multiple risk factors was significantly associated with HBV infection. Hence, 
screening pregnant women regardless of risk factors and improving awareness of the transmission routes of 
HBV within this group may reduce the risk of HBV infections. 
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INTRODUCTION
Hepatitis B virus (HBV) is a major blood-borne and sexually 
transmitted infectious agent, and represents a serious global 
public health problem. HBV is approximately 100 times more 
contagious than human immunodeficiency virus (HIV) and is 
found in diverse populations and subpopulations [1,2]. Global-
ly, 350 million people are chronic carriers. Of these, one million 
of them are expected to suffer serious illness and death from 
cirrhosis and hepatocellular carcinoma (HCC) [3]. Africa has 
the second largest number of chronic carriers after Asia, and is 
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considered a region of high endemicity (≥8%) [3]. Although it 
is difficult to assess the exact burden of HBV in Africa, between 
56% and 98% of the adult population show evidence of past 
exposure to HBV infection, and the seroprevalence of hepatitis 
B surface antigen (HBsAg) has been estimated to range from 
6% to 20% [4]. In Ethiopia, studies among pregnant women 
have shown moderate endemicity, with the prevalence of HB-
sAg positivity ranging from 3% to 6.1% [5-9]. 
HBV is transmitted through parenteral or mucosal exposure 
to infected blood and body fluids, usually either by a vertical or 
horizontal route early in life in highly endemic areas, resulting 
in a high rate of chronic infections [10]. The rates of new infec-
tions and acute disease are highest among adults, but chronic 
infection is more likely to occur in persons infected as infants 
or young children. Chronically infected persons have an incre-
ased lifetime risk for cirrhosis and HCC, and also serve as the 
main reservoir for continued HBV transmission due to its large-
ly asymptomatic nature [2,3]. HBV infection during pregnancy 
is also associated with a high risk of maternal complications 
and has effects on both the mother and child [11]. It has been 
reported that 10% to 20% of HBsAg-positive pregnant women 
transmit the virus to their babies and that those who are positive 
for both HBsAg and HBV antigen have a nearly 100% chance 
of transmitting HBV to their newborns [12]. 
Previous studies in Ethiopia have demonstrated that impor-
tant sources of HBV transmission include blood transfusion; 
tattooing; a history of surgery, unsafe injections, or abortions; 
multiple sexual partners; and traditional practices such as scari-
fication, circumcision, and ear piercing [5-9]. Although the as-
sociation between HIV and HBV has become less prominent in 
Africans, evidence has been found indicating that HIV makes 
HBV-related liver disease develop more quickly [13] and HIV/
HBV co-infection has serious effects on both pregnant women 
and infants. A previous study among pregnant women in Bahir 
Dar city showed an HIV/HBV co-infection rate of 1.3% [8]. 
Preventing mother-to-child transmission of HBV is therefore 
fundamental for reducing the burden of the disease in sub-Sa-
haran Africa, where it is endemic. An effective strategy for re-
ducing the incidence of chronic infections is maternal screening 
combined with post-exposure prophylaxis consisting of HBV 
vaccination immediately after delivery in all infants born to 
HBsAg-positive mothers, jointly with immunoglobulin prophy-
laxis [14]. However, limited information has been published re-
garding the epidemiology of HBV among pregnant women in 
the southern part of Ethiopia. Despite its effects on both the 
mother and child, the routine screening of pregnant women for 
HBV is not practiced in many health facilities in Ethiopia. More-
over, universal immunization of infants against HBV is perform-
ed as part of the National Expanded Program on Immunization 
starting at six weeks. Hence, data regarding HBV in pregnant 
women are fundamental for health planners and caregivers in 
order to support evidence-based interventions. Therefore, the 
aim of this study was to assess the seroprevalence and risk fac-
tors of positive HBsAg status among pregnant women receiv-
ing care at the Hawassa University referral hospital antenatal 
care (ANC) clinic. 
MATERIALS AND METHODS
Study design and area
A cross-sectional study was conducted at the Hawassa Uni-
versity referral hospital from April to May, 2015. The hospital is 
located in Hawassa, the capital city of the Southern Nations, 
Nationalities and Peoples’ Region, 275 km south from the capi-
tal of Ethiopia, Addis Ababa, and is a tertiary-level teaching hos-
pital that provides health services to over 12 million inhabitants 
in the region. The hospital ANC clinic provides routine antena-
tal screening services, such as HIV testing, hemoglobin deter-
mination, blood group testing, rapid plasma reagin testing, and 
urinalysis (for glucose, proteins, and infection) for more than 20 
pregnant women per day. 
Study subjects
A total of 269 consecutive pregnant women attending ante-
natal consultations at the ANC clinic of the Hawassa University 
referral hospital were enrolled during the study period, with a 
participation rate of 100%. Pregnant women who experienced 
bleeding and required urgent interventions were excluded from 
the study.
Data collection
After obtaining informed written consent from each partici-
pant, sociodemographic information and data about potential 
risk factors were collected using a structured questionnaire by 
an experienced midwife nurse.
Blood sample collection, transport, and processing
Approximately 5 mL of venous blood were collected from 
each pregnant woman. After clotting, serum was separated from 
the whole blood and rapid HBsAg testing was performed to de-
liver the result on the same day. The leftover serum samples were 
separated and stored at -20°C at Hawassa University referral 
hospital laboratory. After sample collection, frozen serum sam-
ples were transported to a regional blood bank using a cold box. 
Laboratory testing 
All samples were tested for HBsAg using rapid diagnostic tests 
employing the principle of immunochromatography (SD Bio-
line, Yongin, Korea). The SD BioLine HBsAg One Step Test is a 
3Metaferia Y et al.: Seroprevalence of HBV among pregnant women
qualitative, solid phase, two-site sandwich immunoassay for the 
detection of HBsAg in serum or plasma. The membrane is pre-
coated with anti-HBsAg antibodies on the test band region and 
anti-mouse antibodies on the control band region. During test-
ing, the serum sample reacts with the dye conjugate (mouse an-
ti-HBsAg antibody colloidal gold conjugate) that was coated on 
the test strip. The mixture then reacts with anti-HBsAg antibod-
ies on the membrane via capillary action and generates a red 
band. The presence of two red bands indicates a positive result. 
One red band at the control line indicates a negative result, while 
the absence of a red band at the control line indicates an invalid 
result. For further confirmation, the stored serum samples were 
transported to a regional blood bank and tested using an en-
zyme-linked immunosorbent assay (ELISA) (Dialab GmbH, 
Wiener Neudorf, Austria) [15]. Routine HIV testing in Ethiopia 
is uniformly performed using the established national rapid test-
ing algorithm: the Kehua Bioengineering (KHB) test kit (Shang-
hai, China) is used as a screening test, followed by the HIV1/2 
STAT-PAK assay if positive. If the STAT-PAK and KHB results 
are discordant, the Unigold HIV test is used as a tiebreaker to 
determine the result.
Quality assurance
The validity and completeness of the data were verified by 
the principal investigator daily. The performance of the rapid 
HBsAg test kit was evaluated using known positive and nega-
tive controls obtained from ELISA-tested blood donors. Fur-
thermore, the formation of a colored band at the control line 
acted as a procedural control and further validated the results. 
Based on the instructions in the manufacturer kit, positive and 
negative controls were used for each ELISA reagent lot and pos-
itive results were repeated.
Definition 
The prevalence of HBV infections was determined using se-
rologically positive results for HBsAg using the ELISA method.
Data management and analysis 
The data were coded, entered, cleaned, and analyzed using 
SPSS version 20.0 (IBM Corp., Armonk, NY, USA). Descriptive 
statistics and binary logistic regression analyses were carried 
out to describe the variables and to identify factors associated 
with HBV infection, respectively. Odds ratios (ORs) and 95% 
confidence intervals (CIs) were calculated, and p-values <0.05 
were considered to indicate statistical significance.
Ethical considerations
Ethical approval was obtained from the Department of Re-
search and Ethical Review Committee of the Medical Labora-
tory Sciences, Addis Ababa University. Written consent was also 
obtained from the institutional review board of the College of 
Medicine and Health Sciences of Hawassa University and sub-
mitted to the ANC clinic of the hospital. Informed written con-
sent was also obtained from the study participants for the col-
lection of their sociodemographic data, the HIV results from their 
records, and to use their serum samples for HBsAg screening. A 
code number was used to ensure the confidentiality of the par-
ticipants’ information. No participants paid for the tests that were 
performed and the results were given to the clinicians working 
in the ANC clinic on the same day for further diagnosis and 
ma nagement.
RESULTS
Sociodemographic characteristics
A total of 269 women attending the ANC clinic of the Ha-
wassa University referral hospital from April to May, 2015 were 
enrolled in this study. The mean (standard deviation) age of the 
study participants was 26.0±4.5 years (range, 18-39 years), 
and a plurality (39.4%) were in the age category of 26 to 30 
years. The majority of the study participants lived in urban ar-
eas (84.0%), a plurality were housewives (39.4%, n=106), and 
almost one-fourth of these women had an education level of 
less than secondary school (Table 1).
Prevalence of HBV infection
Using the ELISA test as a reference, the overall seropreva-
lence of HBsAg was 7.8% (n=21). However, four of those sam-
ples were found to be negative by the rapid HBsAg test. As shown 
in Table 1, the study participants with no formal education were 
more likely to be infected (OR, 3.68; 95% CI, 1.27 to 10.68; 
p<0.05) than those who had completed secondary school. How-
ever, none of the other sociodemographic variables showed a 
significant association with HBV infection (Table 1). 
Risk factors for HBV infection
A total of 202 (75.1%) participants had been circumcised 
early in life, while 91 (33.8%) had been hospitalized at some 
time during their lives, 74 (27.5%) had a past history of abor-
tion, 57 (21.2%) had undergone surgical procedures, 49 (18.2%) 
had a history of tattooing, and 39 (14.5%) had a history of mul-
tiple sexual partners. Only nine (3.3%) had received blood prod-
ucts, all of whom were negative for HBV. None of the respon-
dents were aware of their HBV status or had been immunized 
against HBV. However, all of the study participants were screen-
ed for HIV during their ANC visit. The overall HIV seropreva-
lence rate was 5.2% (n=14), of whom nine (64.3%) were on 
antiretroviral therapy. Two of the HIV-positive participants (14.2%) 
were also positive for HBsAg, giving a 0.74% HIV/HBV co-in-
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Table 1. Seroprevalence of HBV and sociodemographic characteristics of pregnant women attending antenatal care at the Hawassa Uni-
versity referral hospital from April to May, 2015
Variable Total 
HBV status of mothers
Positive Negative Crude OR  (95% CI) p-value               
Age (yr)
   18-20
   21-25
   26-30
   31-39
43 (16.0)
84 (31.2)
106 (39.4)
36 (13.4)
3 (7.0)
6 (7.1)
9 (8.5)
3 (8.3)
40 (93.0)
78 (92.9)
97 (91.5)
33 (91.7)
1.00 (reference)
1.03 (0.24, 4.32)
1.24 (0.32, 4.81)
1.21 (0.23, 6.41)
0.97
0.76
0.82
Residence
   Urban
   Rural
226 (84.0)
43 (16.0)
16 (7.1)
5 (11.6)
210 (92.9)
38 (88.4)
1.00 (reference)
1.73 (0.60, 4.99) 0.31
Educational status
   No formal education
   Primary 
   Secondary  or above
31 (11.5)
42 (15.6)
196 (72.8)
6 (19.4)
3 (7.1)
12 (6.1)
25 (80.6)
39 (92.9)
184 (93.9)
3.68 (1.27, 10.68)
1.18 (0.32, 4.38)
1.00 (reference)
0.02
0.80
Occupation 
   Employed 
   Housewife 
   Daily laborer 
   Merchant 
   Student 
99 (36.8)
106 (39.4)
6 (2.2)
38 (14.1)
20 (7.4)
4 (4.0)
10 (9.4)
1 (16.7)
3 (7.9)
3 (15.4)
95 (96.0)
96 (90.6)
5 (83.3)
35 (92.1)
17 (85.0)
1.00 (reference)
2.47 (0.75, 8.16)
4.75 (0.44, 50.74)
2.04 (0.43, 9.56)
4.19 (0.86, 20.42)
0.14
0.20
0.37
0.08
Gestational age
   1st  trimester
   2nd trimester 
   3rd trimester
87 (32.3)
80 (29.7)
102 (37.9)
10 (11.5)
6 (7.5)
5 (4.9)
77 (88.5)
74 (92.5)
97 (95.1)
2.52 (0.83, 7.68)
1.57 (0.46, 5.35)
1.00 (reference)
0.10
0.47
Previous place of delivery 
   No birth
   Home
   Health institution 
109 (40.5)
47 (17.5)
113 (42.0)
6 (5.5)
6 (12.8)
9 (8.0)
103 (94.5)
41 (87.2)
104 (92.0)
1.00 (reference)
2.51 (0.77, 8.24)
1.49 (0.51, 4.32)
0.13
0.47
Values are presented as number (%).
HBV, hepatitis B virus; OR, odds ratio; CI, confidence interval.
Table 2. Risk factors and prevalence of HBsAg among pregnant women attending antenatal care at the Hawassa University referral hospi-
tal from April to May, 2015
Variable 
HBV status of mothers (n=269)
Total Neg Pos Crude OR (95% CI) p-value
History of blood transfusions Yes
No 
9 (3.3)
260 (96.7)
9 (100)
239 (91.9)
0 (0.0)
21 (8.1)
0.00
1.00 (reference)
0.99
Multiple sexual partners Yes
No
39 (14.5)
230 (85.5)
37 (94.9)
211 (91.7)
2 (5.1)
19 (8.3)
0.61 (0.13, 2.69)
1.00 (reference)
0.09
Hospital admissions Yes
No
91 (33.8)
178 (66.2)
83 (91.2)
165 (92.7)
8 (8.8)
13 (7.3)
1.23 (0.49, 3.07)
1.00 (reference)
0.67
Circumcision Yes
No
202 (75.1)
67 (24.9)
183 (90.6)
65 (97.0)
19 (9.4)
2 (3.0)
3.40 (0.76, 14.89)
1.00 (reference)
0.11
Surgical procedures Yes
No
57 (21.2)
212 (78.8)
51 (89.5)
197 (92.9)
6 (10.5)
15 (7.1)
1.52 (0.57,  4.18)
1.00 (reference)
0.39
Body tattooing Yes
No
49 (18.2)
220 (81.8)
46 (93.9)
202 (91.8)
3 (6.1)
18 (8.2)
0.73 (0.21, 2.59)
1.00 (reference)
0.63
History of abortion Yes
No
74 (27.5)
195 (72.5)
67 (90.5)
181 (92.8)
7 (9.5)
14 (7.2)
1.40 (0.52, 3.49)
1.00 (reference)
0.53
HIV/AIDS status Neg
Pos 
255 (94.8)
14 (5.2)
236 (92.5)
12 (85.7)
19 (7.5)
2 (14.3)
1.00 (reference)
2.07 (0.43, 9.93)
0.36
Risk exposure status No 
1
≥2
25 (9.3)
97 (36.1)
147 (54.6)
24 (96.0)
90 (92.8)
134 (91.2)
1 (4.0)
7 (7.2)
13 (8.8)
1.00 (reference)
1.87 (0.22, 15.91)
2.33 (0.29-18.63)
0.57
0.43
Values are presented as number (%).
HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; Neg, negative; Pos, positive; OR,  odds ratio; CI, confidence interval. HIV, human immunodefi-
ciency virus; AIDS, acquired immune deficiency syndrome.
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fection rate. Although the difference was not statistically signifi-
cant, HIV-positive women had higher odds of HBV infection 
(OR, 2.07; 95%CI, 0.43 to 9.93; p=0.36) than their counter-
parts. Of the study participants, 25 (9.3%) had no potential 
risks for exposure, whereas 36.1% had one type of exposure 
and 54.6% had a history of multiple exposures (range, 2 to 5 
risk factors). Neither the type of potential risk factors nor mul-
tiple exposure status was significantly associated with HBV in-
fection (Table 2).
DISCUSSION
In highly endemic areas, antenatal HBV screening is of para-
mount importance for health planners and program managers 
to develop prevention strategies in populations at risk for dis-
ease transmission. In this study, the overall seroprevalence of 
HBsAg in pregnant women was 7.8%. This shows a level of en-
demicity of HBV infection qualifying as almost high according 
to the criteria of the World Health Organization [1]. This preva-
lence rate is higher than has been reported in previous studies 
in different regions of Ethiopia, such as 6.1% in a rural hospital 
in southern Ethiopia [7], 3% in Addis Ababa [9], 3.7% in Jim-
ma [5], 5.3% in Debre-Tabor Hospital [6], and 3.8% in Bahir 
Dar city [8], Ethiopia. However, comparable or higher results 
have been reported in other African countries, such as 8.0% in 
Mali [16], 8.3% in Nigeria [17], 9.3% in Kenya [18], 9.5% in 
Gabon [19], 10.2% in Cameroon [20], and 12.6% in Ghana 
[21]. Variations in prevalence both within and outside of Ethio-
pia may be due to differences in the methods used for screen-
ing for HBsAg, geographical variations, and cultural and behav-
ioral differences regarding possible risk factors of HBV infection. 
In developed nations, where regular screening and vaccination 
for HBV are performed, low prevalence rates (<2%) have been 
reported in pregnant women, such as 0.14% to 0.97%in the 
US (excluding Asian-Americans) [22], 0.9% in Brazil [23], 1.65% 
in Mexico [24], and1.6% in Saudi Arabia [25]. Similar practices 
in developing countries may reduce mother-to-child transmis-
sion and the public health significance of HBV infections.
Study participants with no formal education had higher odds 
of HBV infection than those who had completed at least sec-
ondary school. Other studies have also noted that the seroprev-
alence of HBV infection decreased with increasing levels of ed-
ucation [5,11,17]. This may be due to differences in the level of 
awareness about the transmission of HBV. In this study, age was 
found to have no significant associations with HBV infection, in 
agreement with some studies conducted elsewhere [8,9,26,27]. 
However, other studies have reported that HBV infection in preg-
nant women increased with age [24] and a significantly higher 
prevalence was observed in women between the ages of 20 to 
24 years [5,28]. Moreover, a higher rate of HBV was observed 
among daily laborers and students, in contrast to women with 
regular employment, but this finding was not statistically signif-
icant. 
Of the 14 women who were HIV-positive, only two women 
tested positive for HBsAg. Although this finding was not statis-
tically significant, HIV-positive women had a higher likelihood 
of HBV infection than their counterparts, in agreement with 
other studies [9,29]. In contrast to our study, previous study in 
Cameroon [20] have found that HIV infection was closely asso-
ciated with HBV infection. In this study, the HIV/HBV co-infec-
tion rate was 0.74%. This finding is comparable with previous 
studies conducted in a rural hospital in southern Ethiopia (0.6%) 
[7] and among urban pregnant women in Yaoundé (0.74%) [30]. 
However, this rate is lower than co-infection rates that have been 
reported in northwest Ethiopia (1.3%) [8] and Cameroon (1.5%) 
[20], and significantly lower than the rate that has been report-
ed in Nigeria (4.2%) [17]. Differences in the co-infection rate 
may be due to 64.3% of HIV-positive women in our study were 
on antiretroviral therapy, which may reduce the replication of 
HBV-DNA levels that ultimately decreases viral antigen below 
the detection limit (occult hepatitis) and probably increase spon-
taneous clearance of the virus. 
In this study, neither the type of potential risk factors nor mul-
tiple exposure status was significantly associated with HBV in-
fection, in accordance with a previous study conducted in Addis 
Ababa [9]. However, other studies in Ethiopia and African coun-
tries have reported that blood transfusion [8,20]. body tattoo-
ing [6,8,17,27], circumcision [27], and surgery [6,8,20] were 
potential risk factors for HBV infection. Likewise, HBsAg posi-
tivity was previously reported to be significantly higher in preg-
nant women who had a previous history of abortion [5,28]. How-
ever, no significant association between previous history of abor-
tion and HBsAg positivity was observed in our study. This may 
be due to the implementation of policies aimed at reducing the 
incidence of unsafe abortions, health education related to HIV, 
and the promotion of the use of barriers as contraception.
Nevertheless, the absence of associations between various 
risk factors and HBV infection may have been due to the small 
sample size. Moreover, as a hospital-based study that used a 
non-probabilistic sampling method, selection bias may be intro-
duced, potentially hindering the generalizability of our results 
to all pregnant women in the study area. 
In summary, a high prevalence of HBV infection was detected 
among pregnant women in the study area. Study participants 
with no formal education had higher odds of infection than those 
with at least a secondary-school education. Neither the type of 
potential risk factors nor multiple exposure status was signifi-
cantly associated with HBV infection. Screening of pregnant 
women for HBV regardless of risk factors and increasing aware-
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ness regarding transmission and prevention may reduce the risk 
of infections. This finding provides insights for policy makers and 
concerned bodies about screening pregnant women for HBV 
during their ANC follow-up visits. During data collection, those 
who were HBsAg-positive were referred to the attending physi-
cian, but it was not possible to find supplies for immunoglobu-
lin prophylaxis either in the hospital pharmacy or in the town. 
Therefore, our findings may provide an impetus for suppliers to 
start providing immunoglobulin to vaccinate newborns imme-
diately after delivery.
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